Rafael Carmena

8.8k total citations
154 papers, 4.6k citations indexed

About

Rafael Carmena is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Rafael Carmena has authored 154 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Surgery, 65 papers in Endocrinology, Diabetes and Metabolism and 34 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Rafael Carmena's work include Lipoproteins and Cardiovascular Health (63 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (49 papers) and Lipid metabolism and disorders (19 papers). Rafael Carmena is often cited by papers focused on Lipoproteins and Cardiovascular Health (63 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (49 papers) and Lipid metabolism and disorders (19 papers). Rafael Carmena collaborates with scholars based in Spain, United States and United Kingdom. Rafael Carmena's co-authors include Juan F. Ascaso, José T. Real, Jean‐Charles Fruchart, Patrick Duriez, Antonia Priego, D. J. Betteridge, Rosario I. Lorente, Felipe Javier Chaves, Scott M. Grundy and Philip J. Barter and has published in prestigious journals such as The Lancet, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Rafael Carmena

142 papers receiving 4.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rafael Carmena Spain 32 2.1k 2.1k 911 697 599 154 4.6k
Juan Pedro‐Botet Spain 39 1.8k 0.9× 2.2k 1.1× 936 1.0× 549 0.8× 664 1.1× 298 5.2k
John H. Contois United States 28 1.6k 0.8× 1.6k 0.8× 686 0.8× 405 0.6× 442 0.7× 49 3.5k
Evangelos Liberopoulos Greece 42 2.2k 1.0× 2.3k 1.1× 1.1k 1.2× 937 1.3× 1.3k 2.1× 292 6.2k
Jari Stengård Finland 24 1.4k 0.6× 1.6k 0.8× 779 0.9× 1.2k 1.8× 430 0.7× 52 5.0k
Jane Armitage United Kingdom 31 1.2k 0.6× 2.6k 1.3× 1.2k 1.3× 807 1.2× 535 0.9× 92 5.7k
Handrean Soran United Kingdom 39 1.9k 0.9× 2.6k 1.3× 1.5k 1.6× 850 1.2× 541 0.9× 212 5.9k
P. Barton Duell United States 33 1.0k 0.5× 2.6k 1.2× 745 0.8× 619 0.9× 338 0.6× 114 4.7k
Theodosios D. Filippatos Greece 41 2.3k 1.1× 1.9k 0.9× 722 0.8× 998 1.4× 778 1.3× 142 4.8k
Sarah Parish United Kingdom 33 959 0.5× 1.4k 0.6× 1.2k 1.3× 528 0.8× 462 0.8× 84 3.9k
Hanna Mäenpää Finland 22 1.7k 0.8× 2.0k 1.0× 746 0.8× 945 1.4× 318 0.5× 54 4.8k

Countries citing papers authored by Rafael Carmena

Since Specialization
Citations

This map shows the geographic impact of Rafael Carmena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rafael Carmena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rafael Carmena more than expected).

Fields of papers citing papers by Rafael Carmena

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rafael Carmena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rafael Carmena. The network helps show where Rafael Carmena may publish in the future.

Co-authorship network of co-authors of Rafael Carmena

This figure shows the co-authorship network connecting the top 25 collaborators of Rafael Carmena. A scholar is included among the top collaborators of Rafael Carmena based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rafael Carmena. Rafael Carmena is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Redón, Josep & Rafael Carmena. (2024). Present and future of drug therapy in hypertension: an overview. Blood Pressure. 33(1). 2320401–2320401. 6 indexed citations
2.
Martínez‐Hervás, Sergio, José T. Real, Rafael Carmena, & Juan F. Ascaso. (2023). Prevención cardiovascular en la diabetes mellitus. ¿Es adecuado hablar de riesgo moderado o intermedio?. Clínica e Investigación en Arteriosclerosis. 36(2). 80–85.
3.
Carmena, Rafael, Juan F. Ascaso, & Josep Redón. (2020). Chronic kidney disease as a cardiovascular risk factor. Journal of Hypertension. 38(11). 2110–2121. 22 indexed citations
4.
Ascaso, Juan F. & Rafael Carmena. (2015). Importancia de la dislipidemia en la enfermedad cardiovascular: un punto de vista. Clínica e Investigación en Arteriosclerosis. 27(6). 301–308. 10 indexed citations
5.
Cortés, Raquel, Sergio Martínez‐Hervás, Carmen Ivorra, et al.. (2014). Enhanced reduction in oxidative stress and altered glutathione and thioredoxin system response to unsaturated fatty acid load in familial hypercholesterolemia. Clinical Biochemistry. 47(18). 291–297. 7 indexed citations
6.
Silbernagel, Günther, M. John Chapman, Bernd Genser, et al.. (2013). High Intestinal Cholesterol Absorption Is Associated With Cardiovascular Disease and Risk Alleles in ABCG8 and ABO. Journal of the American College of Cardiology. 62(4). 291–299. 76 indexed citations
7.
Martínez‐Hervás, Sergio, et al.. (2012). Establishing cut-off values for apolipoprotein B and non-HDL-C according to LDL-C values in a South European population. International Journal of Clinical Practice. 67(1). 81–88. 10 indexed citations
8.
Abellán, Rosario, María Luisa Mansego, Sergio Martínez‐Hervás, et al.. (2011). Dietary polyunsaturated fatty acids may increase plasma LDL-cholesterol and plasma cholesterol concentrations in carriers of an ABCG1 gene single nucleotide polymorphism: Study in two Spanish populations. Atherosclerosis. 219(2). 900–906. 16 indexed citations
9.
Real, José T., Sergio Martínez‐Hervás, M. Carmen Tormos, et al.. (2009). Increased oxidative stress levels and normal antioxidant enzyme activity in circulating mononuclear cells from patients of familial hypercholesterolemia. Metabolism. 59(2). 293–298. 22 indexed citations
10.
Carmena, Rafael. (2008). High Risk of Lipoprotein Dysfunction in Type 2 Diabetes Mellitus. Revista Española de Cardiología. 8. 18–24. 8 indexed citations
11.
Martínez‐Hervás, Sergio, José T. Real, O. Espinosa, et al.. (2008). Insulin resistance and oxidative stress in familial combined hyperlipidemia. Atherosclerosis. 199(2). 384–389. 31 indexed citations
12.
Arango, Celso, Julio Bobes, Pedro J. Aranda, et al.. (2008). A comparison of schizophrenia outpatients treated with antipsychotics with and without metabolic syndrome: Findings from the CLAMORS study. Schizophrenia Research. 104(1-3). 1–12. 80 indexed citations
13.
Martínez‐Hervás, Sergio, Ana-Bárbara García-García, Manuel Castro Cabezas, et al.. (2006). Efecto del género y de la obesidad en la lipemia posprandial en sujetos sanos normolipidémicos no diabéticos y sujetos con hiperlipemia familiar combinada. Revista Clínica Española. 206(5). 213–219. 2 indexed citations
14.
Bobes, Julio, et al.. (2006). Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: Results of the CLAMORS Study. Schizophrenia Research. 90(1-3). 162–173. 161 indexed citations
15.
García-García, Ana-Bárbara, José T. Real, José Javier Martı́n de Llano, et al.. (2005). Influence of microsomal triglyceride transfer protein promoter polymorphism −493 GT on fasting plasma triglyceride values and interaction with treatment response to atorvastatin in subjects with heterozygous familial hypercholesterolaemia. Pharmacogenetics and Genomics. 15(4). 211–218. 23 indexed citations
16.
Carmena, Rafael & D. J. Betteridge. (2004). Statins and Diabetes. Seminars in Vascular Medicine. 4(4). 321–332. 21 indexed citations
17.
Chaves, Felipe Javier, José T. Real, Ana-Bárbara García-García, et al.. (2001). Genetic Diagnosis of Familial Hypercholesterolemia in a South European Outbreed Population: Influence of Low-Density Lipoprotein (LDL) Receptor Gene Mutations on Treatment Response to Simvastatin in Total, LDL, and High-Density Lipoprotein Cholesterol. The Journal of Clinical Endocrinology & Metabolism. 86(10). 4926–4932. 71 indexed citations
18.
Carmena, Rafael, Madeleine Roy, Ghislaine O. Roederer, Anne Minnich, & J. Davignon. (2000). Coexisting dysbetalipoproteinemia and familial hypercholesterolemia. Atherosclerosis. 148(1). 113–124. 22 indexed citations
19.
Ascaso, Juan F., et al.. (1998). A study of insulin resistance using the minimal model in nondiabetic familial combined hyperlipidemic patients. Metabolism. 47(5). 508–513. 42 indexed citations
20.
Vayá, Amparo, Marcial Martı́nez, Rafael Carmena, & Justo Aznar. (1993). Red blood cell aggregation and primary hyperlipoproteinemia. Thrombosis Research. 72(2). 119–126. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026